المؤلفون: Groenland, Stefanie L., van Eerden, Ruben A. G., Verheijen, Remy B., Koolen, Stijn L. W., Moes, Dirk Jan A. R., Desar, Ingrid M. E., Reyners, Anna K. L., Gelderblom, Hans J., van Erp, Nielka P., Mathijssen, Ron H. J., Huitema, Alwin D. R., Steeghs, Neeltje

المصدر: Dutch Pharmacology Oncology Grp , Groenland , S L , van Eerden , R A G , Verheijen , R B , Koolen , S L W , Moes , D J A R , Desar , I M E , Reyners , A K L , Gelderblom , H J , van Erp , N P , Mathijssen , R H J , Huitema , A D R & Steeghs , N 2019 , ' Therapeutic Drug Monitoring of Oral Anticancer Drugs : The Dutch Pharmacology Oncology Group-Therapeutic Drug Monitoring Protocol for a Prospective Study ' , Therapeutic ....

مصطلحات موضوعية: TDM, oral anticancer drugs, PK, individualized dosing, personalized dosing, EXPOSURE-RESPONSE ANALYSIS, RENAL-CELL CARCINOMA, KINASE INHIBITORS, DOSE-ESCALATION, HUMAN PLASMA, PHASE-I, IMATINIB, TAMOXIFEN, QUANTIFICATION, PAZOPANIB

وصف الملف: application/pdf

العلاقة: https://research.rug.nl/en/publications/40acb878-8547-4348-8417-1244375732a5Test

الإتاحة: https://doi.org/10.1097/FTD.0000000000000654Test
https://hdl.handle.net/11370/40acb878-8547-4348-8417-1244375732a5Test
https://research.rug.nl/en/publications/40acb878-8547-4348-8417-1244375732a5Test
https://pure.rug.nl/ws/files/118314574/Therapeutic_Drug_Monitoring_of_Oral_Anticancer.3.pdfTest

المؤلفون: Terwisscha Van Scheltinga, Anton, Lub-de Hooge, Marjolijn N., Hinner, Marlon J., Verheijen, Remy B., Allersdorfer, Andrea, Hulsmeyer, Martin, Nagengast, Wouter B., Schroder, Carolien P., Kosterink, Jos G. W., de Vries, Elisabeth G. E., Audoly, Laurent, Olwill, Shane A.

المصدر: Terwisscha Van Scheltinga , A , Lub-de Hooge , M N , Hinner , M J , Verheijen , R B , Allersdorfer , A , Hulsmeyer , M , Nagengast , W B , Schroder , C P , Kosterink , J G W , de Vries , E G E , Audoly , L & Olwill , S A 2014 , ' In Vivo Visualization of MET Tumor Expression and Anticalin Biodistribution with the MET-Specific Anticalin Zr-89-PRS-110 PET Tracer ' , Journal of Nuclear Medicine , vol. 55 , no. 4 , pp. 665-671 . https://doi.org/10.2967/jnumed.113.124941Test

مصطلحات موضوعية: anticalins, Zr-89, PET, MET, GROWTH-FACTOR, MONOCLONAL-ANTIBODIES, CANCER XENOGRAFTS, BINDING-PROTEINS, RECEPTOR, SCAFFOLD, SITE

العلاقة: https://research.rug.nl/en/publications/5805878a-ebf0-4607-93a8-ef4d35c76368Test

الإتاحة: https://doi.org/10.2967/jnumed.113.124941Test
https://hdl.handle.net/11370/5805878a-ebf0-4607-93a8-ef4d35c76368Test
https://research.rug.nl/en/publications/5805878a-ebf0-4607-93a8-ef4d35c76368Test